Superparamagnetic iron oxide nanoparticle probes for molecular imaging

Annals of Biomedical Engineering

Volumn 34, Issue 1, 2006, Pages 23-38

  Thorek, Daniel L J ^a   Chen, Antony K ^a   Czupryna, Julie ^a   Tsourkas, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Magnetic resonance; Molecular imaging; Nanoparticles; SPIO

Indexed keywords

MOLECULAR IMAGING; NANOPARTICLES; SPIO;

DISEASES; IRON OXIDES; MAGNETIC RESONANCE; NANOSTRUCTURED MATERIALS; SUPERPARAMAGNETISM;

MEDICAL IMAGING;

CONTRAST MEDIUM; IRON; NANOMATERIAL; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GENETIC PROCEDURES; HUMAN; IMAGE ENHANCEMENT; MAGNETISM; METHODOLOGY; MOLECULAR PROBE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING; MAGNETICS; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NANOSTRUCTURES; NANOTECHNOLOGY; OXIDES;

EID: 33645214569     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-005-9002-7     Document Type: Article

References (165)

1. Antony, A. C. Folate receptors. Annu. Rev. Nutr. 16:501-521, 1996.
2. Anzai, Y. Superparamagnetic iron oxide nanoparticles: Nodal metastases and beyond. Top. Magn. Reson. Imaging 15:103-111, 2004.
3. Anzai, Y., C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, J. A. Brunberg, I. R. Francis, S. E. Harms, P. M. Som, and C. M. Tempany. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology 228:777-788, 2003.
4. Anzai, Y., M. R. Prince, T. L. Chenevert, J. H. Maki, F. Londy, M. London, and S. J. MacLachlan. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J. Magn. Reson. Imaging 7:75-81, 1997.
5. Arbab, A. S., T. Ichikawa, H. Sou, T. Araki, H. Nakajima, K. Ishigame, T. Yoshikawa, and H. Kumagai. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. Radiology 225:151-158, 2002.
6. Arbab, A. S., G. T. Yocum, L. B. Wilson, A. Parwana, E. K. Jordan, H. Kalish, and J. A. Frank. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imaging 3:24-32, 2004.
7. Ariens, R. A., T. S. Lai, J. W. Weisel, C. S. Greenberg, and P. J. Grant. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743-754, 2002.
8. Artemov, D., N. Mori, B. Okollie, and Z. M. Bhujwalla. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med. 49:403-408, 2003.
9. Artemov, D., N. Mori, R. Ravi, and Z. M. Bhujwalla. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 63:2723-2727, 2003.
10. 3. J. Phys. C Solid State Phys. 21:2229-2245, 1988.
11. Babes, L., B. Denizot, G. Tanguy, J. J. Le Jeune, and P. Jallet. Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study. J. Colloid Interface Sci. 212:474-482, 1999.
12. Banati, R. B., J. Gehrmann, P. Schubert, and G. W. Kreutzberg. Cytotoxicity of microglia. Glia 7:111-118, 1993.
13. Bee, A., R. Massart, and S. Neveu. Synthesis of very fine maghemite particle. J. Magn. Magn. Mater. 149:6-9, 1995.
14. 3 vacancies ordering and lattice parameters. J. Solid State Chem. 163:459-465, 2002.
15. Bischoff, J., C. Brasel, B. Kraling, and K. Vranovska. E-selectin is upregulated in proliferating endothelial cells in vitro. Microcirculation 4:279-287, 1997.
16. Bos, C., Y. Delmas, A. Desmouliere, A. Solanilla, O. Hauger, C. Grosset, I. Dubus, Z. Ivanovic, J. Rosenbaum, P. Charbord, C. Combe, J. W. Bulte, C. T. Moonen, J. Ripoche, and N. Grenier. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver, Radiology 233:781-789, 2004.
17. Brooks, R. A. T(2)-shortening by strongly magnetized spheres: A chemical exchange model. Magn. Reson. Med. 47:388-391, 2002.
18. Bruckl, H., M. Panhorst, J. Schotter, P. B. Kamp, and A. Becker. Magnetic particles as markers and carriers of biomolecules. IEE Proc. Nanobiotechnol. 152:41-46, 2005.
19. Bulte, J. W., S. Zhang, P. van Gelderen, V. Herynek, E. K. Jordan, I. D. Duncan, J. A. Frank. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 96:15256-15261, 1999.
20. Carreno, T. G., A. Mifsud, C. J. Serna, and J. M. Palacios. Preparation of homogeneous Zn/Co mixed oxides by spray pyrolysis. Mater. Chem. Phys. 27:287-296, 1991.
21. Caruso, F., M. Spasova, A. Susha, M. Giersig, and R. A. Caruso. Magnetic nanocomposite particles and hollow spheres constructed by a sequential layering approach. Chem. Mater. 13:109-116, 2001.
22. Caruso, F., A. S. Susha, M. Giersig, and H. Mohwald. Magnetic core-shell particles: Preparation of magnetite multilayers on polymer latex microspheres. Adv. Mater. 11:950, 1999.
23. Chapman, P. T., F. Jamar, E. T. Keelan, A. M. Peters, and D. O. Haskard. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum. 39:1371-1375, 1996.
24. Choi, H., S. R. Choi, R. Zhou, H. F. Kung, and I. W. Chen. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad. Radiol. 11:996-1004, 2004.
25. Cornell, R. M., and U. Schertmann. The Iron Oxides: Structure, Properties, Reactions, Occurrence and Uses. Weinheim: VCH Publishers, 1996.
26. Corot, C., K. G. Petry, R. Trivedi, A. Saleh, C. Jonkmanns, J. F. Le Bas, E. Blezer, M. Rausch, B. Brochet, P. Foster-Gareau, D. Baleriaux, S. Gaillard, and V. Dousset. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest. Radiol. 39:619-625, 2004.
27. Daldrup-Link, H. E., M. Rudelius, R. A. Oostendorp, M. Settles, G. Piontek, S. Metz, H. Rosenbrock, U. Keller, U. Heinzmann, E. J. Rummeny, J. Schlegel, and T. M. Link. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228:760-767, 2003.
28. Decher, G. Fuzzy nanoassemblies: Toward layered polymeric multicomposites. Science 277:1232-1237, 1997.
29. Deng, Y., L. Wang, W. Yang, S. Fu, A. Elaissari. Preparation of magnetic polymeric particles via inverse microemulsion polymerization process. J. Magn. Magn. Mater. 257:69-78, 2003.
30. Dodd, C. H., H. C. Hsu, W. J. Chu, P. Yang, H. G. Zhang, J. D. Mountz Jr., K. Zinn, J. Forder, L. Josephson, R. Weissleder, J. M. Mountz, and J. D. Mountz. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J. Immunol. Methods 256:89-105, 2001.
31. Dodd, S. J., M. Williams, J. P. Suhan, D. S. Williams, A. P. Koretsky, and C. Ho. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J. 76:103-109, 1999.
32. Dormer, K., C. Seeney, A. Mamedov, and F. Mondalek. Internalization of nanoparticles in the middle ear epithelium in response to an external magnetic field: Generating a force. Proceedings of Nanotech 2004, 2004.
33. Dousset, V., C. Delalande, L. Ballarino, B. Quesson, D. Seilhan, M. Coussemacq, E. Thiaudiere, B. Brochet, P. Canioni, and J. M. Caille. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn. Reson. Med. 41:329-333, 1999.
34. Edelman, R. R. Contrast-enhanced MR imaging of the heart: Overview of the literature. Radiology 232:653-668, 2004.
35. Elliot, S. R. The Physics and Chemistry of Solids. New York: Wiley, 1998.
36. Emoto, K., N. Toyama-Sorimachi, H. Karasuyama, K. Inoue, and M. Umeda. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res. 232:430-434, 1997.
37. Enochs, W. S., G. Harsh, F. Hochberg, and R. Weissleder. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9:228-232, 1999.
38. Fabry, B., G. N. Maksym, J. P. Butler, M. Glogauer, D. Navajas, and J. J. Fredberg. Scaling the microrheology of living cells. Phys. Rev. Lett. 87:148102, 2001.
39. Fauconnier, N., A. Bee, J. Roger, and J. N. Pons. Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. J. Mol. Liquids 83:233-242, 1999.
40. Flacke, S., S. Fischer, M. J. Scott, R. J. Fuhrhop, J. S. Allen, M. McLean, P. Winter, G. A. Sicard, P. J. Gaffney, S. A. Wickline, and G. M. Lanza. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 104:1280-1285, 2001.
41. Fletcher, F., and E. London. Intravenous iron. Br. Med. J. 84, 1954.
42. Foster-Gareau, P., C. Heyn, A. Alejski, and B. K. Rutt. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn. Reson. Med. 49:968-971, 2003.
43. Frank, J. A., B. R. Miller, A. S. Arbab, H. A. Zywicke, E. K. Jordan, B. K. Lewis, L. H. Bryant Jr., and J. W. Bulte. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480-487, 2003.
44. Funovics, M. A., B. Kapeller, C. Hoeller, H. S. Su, R. Kunstfeld, S. Puig, and K. Macfelda. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn. Reson. Imaging 22:843-850, 2004.
45. Gao, X., L. Yang, J. A. Petros, F. F. Marshall, J. W. Simons, and S. Nie. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16:63-72, 2005.
46. Gilchrist, R. K., R. Medal, W. D. Shorey, R. C. Hanselman, J. C. Parrott, and C. B. Taylor. Selective inductive heating of lymph nodes. Ann. Surg. 146:596-606, 1957.
47. Gillis, P., F. Moiny, and R. A. Brooks. On T(2)-shortening by strongly magnetized spheres: A partial refocusing model. Magn. Reson. Med. 47:257-263, 2002.
48. Goodarzi, A., Y. Sayoo, M. T. Swihart, and P. N. Prasad. Aqueous ferrofluid of citric acid coated magnetite particles. Mater. Res. Soc. Symp. Proc. 789:129-134, 2004.
49. Grimm, J., J. M. Perez, L. Josephson, and R. Weissleder. Novel nanosensors for rapid analysis of telomerase activity. Cancer Res. 64:639-643, 2004.
50. Groman, E. V., K. G. Paul, T. B. Frigo, H. H. Bengele, and J. M. Lewis. Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives, US Patent 6599498, in US, Advanced Magnetics, Inc., 2003.
51. Gupta, A. Iron infusion into the arterial blood line during haemodialysis: A novel method to remove free iron and reduce oxidative damage. Nephrol. Dial. Transplant 15:1482-1484, 2000.
52. Gupta, A. K., and A. S. Curtis. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 15:493-496, 2004.
53. Gupta, A. K., and S. Wells. Surface-modified superparamagnetic nanoparticles for drug delivery: Preparation, characterization, and cytotoxicity studies. IEEE Trans. Nanobiosci. 3:66-73, 2004.
54. Hahn, P. F., D. D. Stark, J. M. Lewis, S. Saini, G. Elizondo, R. Weissleder, C. J. Fretz, and J. T. Ferrucci. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175:695-700, 1990.
55. Harisinghani, M. G., J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348:2491-2499, 2003.
56. 4 superparamagnetic nanocrystals for biological applications. J. Phys. D Appl. Phys. 38:1342-1350, 2005.
57. Herschman, H. R. Molecular imaging: Looking at problems, seeing solutions. Science 302:605-608, 2003.
58. Hinds, K. A., J. M. Hill, E. M. Shapiro, M. O. Laukkanen, A. C. Silva, C. A. Combs, T. R. Varney, R. S. Balaban, A. P. Koretsky, and C. E. Dunbar. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102:867-872, 2003.
59. Hochepied, J. F., and M. P. Pileni. Magnetic properties of mixed cobalt-zinc ferrite nanoparticles. J. Appl. Phys. 87:2472-2478, 2000.
60. Hogemann, D., L. Josephson, R. Weissleder, J. P. Basilion. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug. Chem. 11:941-946, 2000.
61. Hundt, W., R. Petsch, T. Helmberger, and M. Reiser. Effect of superparamagnetic iron oxide on bone marrow. Eur. Radiol. 10:1495-1500, 2000.
62. Ichikawa, T., D. Hogemann, Y. Saeki, E. Tyminski, K. Terada, R. Weissleder, E. A. Chiocca, and J. P. Basilion. MRI of transgene expression: Correlation to therapeutic gene expression. Neoplasia 4:523-530, 2002.
63. Igartua, M., P. Saulnier, B. Heurtault, B. Pech, J. E. Proust, J. L. Pedraz, and J. P. Benoit. Development and characterization of solid lipid nanoparticles loaded with magnetite. Int. J. Pharm. 233:149-157, 2002.
64. Jaffer, F. A., and R. Weissleder. Seeing within: Molecular imaging of the cardiovascular system. Circ. Res. 94:433-445, 2004.
65. Johansson, L. O., A. Bjornerud, H. K. Ahlstrom, D. L. Ladd, and D. K. Fujii. A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution. J. Magn. Reson. Imaging 13:615-618, 2001.
66. Jolivet, J. P. Metal Oxide Chemistry and Synthesis: From Solutions to Solid State. New York: Wiley, 2000.
67. Josephson, L., J. M. Perez, and R. Weissleder. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem. Int. Ed. Engl. 40:3204, 2001.
68. Josephson, L., C. H. Tung, A. Moore, and R. Weissleder. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10:186-191, 1999.
69. Kachra, Z., E. Beaulieu, L. Delbecchi, N. Mousseau, F. Berthelet, R. Moumdjian, R. Del Maestro, and R. Beliveau. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin. Exp. Metastasis 17:555-566, 1999.
70. Kang, H. W., L. Josephson, A. Petrovsky, R. Weissleder, and A. Bogdanov Jr. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug. Chem. 13:122-127, 2002.
71. Kanno, S., Y. J. Wu, P. C. Lee, S. J. Dodd, M. Williams, B. P. Griffith, and C. Ho. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104:934-938, 2001.
72. Kelly, K. A., J. R. Allport, A. Tsourkas, V. R. Shinde-Patil, L. Josephson, and R. Weissleder. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 96:327-336, 2005.
73. Kemshead, J. T., and J. Ugelstad. Magnetic separation techniques: Their application to medicine. Mol. Cell. Biochem. 67:11-18, 1985.
74. Kim, D. K., W. Voit, W. Zapka, B. Bjelke, M. Muhammed, and K. V. Rao. Biomedical application of ferrofluids containing magnetite nanoparticles. Mater. Res. Soc. Symp. Proc. 676: y8.32.31.31-36, 2001.
75. Kooi, M. E., V. C. Cappendijk, K. B. Cleutjens, A. G. Kessels, P. J. Kitslaar, M. Borgers, P. M. Frederik, M. J. Daemen, and J. M. van Engelshoven. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107:2453-2458, 2003.
76. Kraling, B. M., M. J. Razon, L. M. Boon, D. Zurakowski, C. Seachord, R. P. Darveau, J. B. Mulliken, C. L. Corless, and J. Bischoff. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am. J. Pathol. 148:1181-1191, 1996.
77. Kresse, M., S. Wagner, D. Pfefferer, R. Lawaczeck, V. Elste, and W. Semmler. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn. Reson. Med. 40:236-242, 1998.
78. LaConte, L. E., N. Nitin, and G. Bao. Magnetic nanoparticle probes. Mater. Today 8(Suppl. 1):32-38, 2005.
79. Lee, S.-J., J.-R. Leong, S.-C. Shin, J.-C. Kim, Y.-H. Chang, Y.-M. Chang, and J.-D. Kim. Nanoparticles of magnetic ferric oxides encapsulated with poly(D,L latide-co-glycolide) and their applications to magnetic resonance imaging contrast agent. J. Magn. Magn. Mater. 272-276:2432-2433, 2004.
80. Lewin, M., N. Carlesso, C. H. Tung, X. W. Tang, D. Cory, D. T. Scadden, and R. Weissleder. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:410-414, 2000.
81. Li, Z., H. Chen, H. B. Bao, and M. Y. Gao. One-pot reaction to synthesize water-soluble magnetite nanocrystals. Chem. Mater. 16:1391-1393, 2004.
82. Lind, K., M. Kresse, N. P. Debus, and R. H. Muller. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: Comparison of physicochemical properties and the in vivo behaviour. J. Drug Target 10:221-230, 2002.
83. London, E. The molecular formula and proposed structure of the iron-dextran complex, imferon. J. Pharm. Sci. 93:1838, 2004.
84. Louie, A. Y., M. M. Huber, E. T. Ahrens, U. Rothbacher, R. Moats, R. E. Jacobs, S. E. Fraser, and T. J. Meade. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:321-325, 2000.
85. Lu, Y., B. T. Mayers, and Y. Xia. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett. 2:183-186, 2002.
86. Mack, M. G., J. O. Balzer, R. Straub, K. Eichler, and T. J. Vogl. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222:239-244, 2002.
87. Massart, R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 17:1247-1248, 1981.
88. Massart, R. Magnetic fluids and process for obtaining them, US Patent 4329241, in US, 1982.
89. Massart, R., E. Dubois, V. Cabuil, and E. HasmonayPreparation and properties of monodisperse magnetic fluids. J. Magn. Magn. Mater. 149:1-5, 1995.
90. Matuszewski, L., T. Persigehl, A. Wall, W. Schwindt, B. Tombach, M. Fobker, C. Poremba, W. Ebert, W Heindel, and C. Bremer. Cell tagging with clinically approved iron oxides: Feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235:155-161, 2005.
91. Moffat, B. A., G. R. Reddy, P. McConville, D. E. Hall, T. L. Chenevert, R. R. Kopelman, M. Philbert, R. Weissleder, A. Rehemtulla, and B. D. Ross. A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol. Imaging 2:324-332, 2003.
92. Molday, R. S. Magnetic iron-dextran microspheres, US Patent 4452773, in 1984.
93. Molday, R. S., and D. MacKenzie. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immunol. Methods 52:353-367, 1982.
94. Moore, A., J. Basilion, A. Chiocca, and R. Weissleder. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta 1402:239-249, 1998.
95. Moore, A., E. Marecos, A. Bogdanov Jr., and R. Weissleder. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568-574, 2000.
96. Moore, A., Z. Medarova, A. Potthast, and G. Dai. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multi-modal imaging probe. Cancer Res. 64:1821-1827, 2004.
97. Morais, P. C. P. P. Gravina, A. F. Bakuzis, K. Skeff Neto, and E. C. D. Lima. Magneto-optical properties of ionic magnetic fluids: The effect of the nanoparticle surface passivation. Phys. Status Solidi C 1:3575-3578, 2004.
98. 3 nanoparticles. Chem. Mater. 11:3058, 1999.
99. Morawski, A. M., P. M. Winter, K. C. Crowder, S. D. Caruthers, R. W. Fuhrhop, M. J. Scott, J. D. Robertson, D. R. Abendschein, G. M. Lanza, and S. A. Wickline. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn. Reson. Med. 51:480-486, 2004.
100. Mornet, S., S. Vasseur, F. Grasset, and E. Duguet. Magnetic nanoparticles design for medical diagnosis and therapy. Bioconjug. Chem. 14:2161-2175, 2004.
101. Nitin, N., L. E. LaConte, O. Zurkiya, X. Hu, and G. Bao. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorg. Chem. 9:706-712, 2004.
102. Palmacci, S., and L. Josephson. Synthesis of polysaccharide covered superparamagnetic oxid colloids, US Patent 5262176, in US, Advanced Magnetics, Inc., 1993.
103. Papell, S. S. US Patent 3215572, in US, 1965.
104. Passirani, C., G. Barratt, J. P. Devissaguet, and D. Labarre. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm. Res. 15:1046-1050, 1998.
105. Perez, J. M., L. Josephson, T. O'Loughlin, D. Hogemann, and R. Weissleder. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20:816-820, 2002.
106. Perez, J. M., T. O'Loughin, F. J. Simeone, R. Weissleder, and L. Josephson. DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J. Am. Chem. Soc. 124:2856-2857, 2002.
107. Perez, J. M., F. Simeone, A. Tsourkas, L. Josephson, and R. Weissleder. Peroxidase substrate nanosensors for MR imaging. Nano Lett. 4:119-122, 2004.
108. Perez, J. M., F. J. Simeone, Y. Saeki, L. Josephson, and R. Weissleder. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J. Am. Chem. Soc. 125:10192-10193, 2003.
109. Petri-Fink, A., M. Chastellain, L. Juillerat-Jeanneret, A. Ferrari, and H. Hofmann. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26:2685-2694, 2005.
110. Phelps, M. E. PET: A biological imaging technique. Neurochem. Res. 16:929-940, 1991.
111. Pileni, M. P. Reverse Micelles as Microreactors. J. Phys. Chem. 97:6961-6973, 1993.
112. Pileni, M. P. The role of soft colloidal templates in controlling the size and shape of inorganic nanocrystals. Nat. Mater. 2:145-150, 2003.
113. Pillai, V., P. Kumar, M. J. Hou, P. Ayyub, and D. O. Shah. Preparation of nanoparticles of silver-halides, superconductors and magnetic-materials using water-in-oil microemulsions as nano-reactors. Adv. Colloid Interface Sci. 55:241-269, 1995.
114. Qhobosheane, M., S. Santra, P. Zhang, and W. Tan. Biochemically functionalized silica nanoparticles. Analyst 126:1274-1278, 2001.
115. Qian, Z. M., H. Li, H. Sun, and K. Ho. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54:561-587, 2002.
116. Raynal, I., P. Prigent, S. Peyramaure, A. Najid, C. Rebuzzi, and C. Corot. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39:56-63, 2004.
117. Reimer, P., N. Jahnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini. Hepatic lesion detection and characterization: Value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152-158, 2000.
118. Reimer, P., and P. Landwehr. Non-invasive vascular imaging of peripheral vessels. Eur. Radiol. 8:858-872, 1998.
119. Reimer, P., R. Weissleder, A. S. Lee, J. Wittenberg, and T. J. Brady. Receptor imaging: Application to MR imaging of liver cancer. Radiology 177:729-734, 1990.
120. Reimer, P., R. Weissleder, T. Shen, W. T. Knoefel, and T. J. Brady. Pancreatic receptors: Initial feasibility studies with a targeted contrast agent for MR imaging. Radiology 193:527-531, 1994.
121. Reimers, G. W., and S. E. Khalafalla. Preparing magnetic fluids by a peptizing method. Bureau Mines Tech. Prog. Rep. 59, 1972.
122. Rockenberger, J., E. C. Scher, and A. P. Alivisatos. A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides. J. Am. Chem. Soc. 121:11595-11596, 1999.
123. Rosensweig, R. E. Ferrohydrodynamics. Cambridge: Cambridge University Press, 1985.
124. Ruehm, S. G., C. Corot, P. Vogt, H. Cristina, and J. F. Debatin. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits. Acad. Radiol. 9(Suppl 1):S143-S144, 2002.
125. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol. 12:697-715, 1996.
126. Saeed, M., M. F. Wendland, M. Engelbrecht, H. Sakuma, and C. B. Higgins. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities. Eur. Radiol. 8:1047-1053, 1998.
127. Saleh, A., M. Schroeter, C. Jonkmanns, H. P. Hartung, U. Modder, and S. Jander. In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127:1670-1677, 2004.
128. Schellenberger, E. A., A. Bogdanov Jr., D. Hogemann, J. Tait, R. Weissleder, and L. Josephson. Annexin V-CLIO: A nanoparticle for detecting apoptosis by MRI. Mol. Imaging 1:102-107, 2002.
129. Schellenberger, E. A., D. Sosnovik, R. Weissleder, and L. Josephson. Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 15:1062-1067, 2004.
130. Schmitz, S. A., M. Taupitz, S. Wagner, K. J. Wolf, D. Beyersdorff, and B. Hamm. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J. Magn. Reson. Imaging 14:355-361, 2001.
131. Schwertmann, U., and R. M. Cornell. Iron Oxides in the Laboratory, Preparation and Characterization. Cambridge: Wiley-VCH, 2003.
132. Seip, C. T., E. E. Carpenter, C. J. O'Connor, V. T. John, and S. C. Li. Magnetic properties of a series of ferrite nanoparticles synthesized in reverse micelles. IEEE Trans. Magn. 34:1111-1113, 1998.
133. Shamsi, K., T. Balzer, S. Saini, P. R. Ros, R. C. Nelson, E. C. Carter, S. Tollerfield, and H. P. Niendorf. Superparamagnetic iron oxide particles (SH U 555 A): Evaluation of efficacy in three doses for hepatic MR imaging. Radiology 206:365-371, 1998.
134. Shapiro, E. M., S. Skrtic, K. Sharer, J. M. Hill, C. E. Dunbar, and A. P. Koretsky. MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. USA 101:10901-10906, 2004.
135. Shen, T., R. Weissleder, M. Papisov, A. Bogdanov Jr., and T. J. Brady. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties. Magn. Reson. Med. 29:599-604, 1993.
136. Skold, C. N. Magnetic particles and methods of producing coated magnetic particles, US Patent App. 20020000398, in US, 2002.
137. Sorensen, C. M. Nanoscale Materials in Chemistry. New York: Wiley, 2001.
138. Sudimack, J., and R. J. Lee. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41:147-162, 2000.
139. Suslick, K. S., M. M. Fang, and T. Hyeon. Sonochemical synthesis of iron colloids. J. Am. Chem. Soc. 118:11960-11961, 1996.
140. Tanimoto, A., K. Oshio, M. Suematsu, D. Pouliquen, and D. D. Stark. Relaxation effects of clustered particles. J. Magn. Reson. Imaging 14:72-77, 2001.
141. Tebble, R. S., and D. J. Craik. Magnetic Materials. London: Wiley-Interscience, 1969.
142. Thorstensen, K., and I. Romslo. The transferrin receptor: Its diagnostic value and its potential as therapeutic target. Scand. J. Clin. Lab. Invest. Suppl. 215:113-120, 1993.
143. Toma, A., E. Otsuji, Y. Kuriu, K. Okamoto, D. Ichikawa, A. Hagiwara, H. Ito, T. Nishimura, and H. Yamagishi. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br. J. Cancer 2005.
144. Tsourkas, A., O. Hofstetter, H. Hofstetter, R. Weissleder, and L. Josephson. Magnetic relaxation switch immunosensors detect enantiomeric impurities. Angew Chem. Int. Ed. Engl. 43:2395-2399, 2004.
145. Tsourkas, A., V. R. Shinde-Patil, K. A. Kelly, P. Patel, A. Wolley, J. R. Allport, and R. Weissleder. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug. Chem. 16:576-581, 2005.
146. Vande Berg, B. C., F. E. Lecouvet, J. P. Kanku, J. Jamart, B. E. Van Beers, B. Maldague, and J. Malghem. Ferumoxides-enhanced quantitative magnetic resonance imaging of the normal and abnormal bone marrow: Preliminary assessment. J. Magn. Reson. Imaging 9:322-328, 1999.
147. Veintemillas-Verdaguer, S., M. P. Morales, and C. J. Serna. Effect of the oxidation conditions on the maghemites produced by laser pyrolysis. Appl. Organometallic Chem. 15:365-372, 2001.
148. Veiseh, O., C. Sun, J. Gunn, N. Kohler, P. Gabikian, D. Lee, N. Bhattarai, R. Ellenbogen, R. Sze, A. Hallahan, J. Olson, and M. Zhang. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 5:1003-1008, 2005.
149. Vogl, T. J., R. Hammerstingl, W. Schwarz, M. G. Mack, P. K. Muller, W. Pegios, H. Keck, A. Eibl-Eibesfeldt, J. Hoelzl, B. Woessmer, C. Bergman, and R. Felix. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881-887, 1996.
150. Wagner, S., J. Schnorr, H. Pilgrimm, B. Hamm, and M. Taupitz. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: Preclinical in vivo characterization. Invest. Radiol. 37:167-177, 2002.
151. Wang, N., J. P. Butler, and D. E. Ingber. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260:1124-1127, 1993.
152. Wang, Y. X., S. M. Hussain, and G. P. Krestin. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11:2319-2331, 2001.
153. Weissleder, R. Monocrystalline iron oxide particles for studying biological tissues, US Patent 5492814, in US, The General Hospital Corporation, 1996.
154. Weissleder, R., A. Bogdanov, E. A. Neuwelt, and M. Papisov. Long-circulating iron oxides for MR imaging. Adv. Drug Deliv. Rev. 16:321-334, 1995.
155. Weissleder, R., G. Elizondo, J. Wittenberg, A. S. Lee, L. Josephson, and T. J. Brady. Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498, 1990.
156. Weissleder, R., G. Elizondo, J. Wittenberg, C. A. Rabito, H. H. Bengele, and L. Josephson. Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging. Radiology 175:489-493, 1990.
157. Weissleder, R., P. F. Hahn, D. D. Stark, G. Elizondo, S. Saini, L. E. Todd, J. Wittenberg, and J. T. Ferrucci. Superparamagnetic iron oxide: Enhanced detection of focal splenic tumors with MR imaging. Radiology 169:399-403, 1988.
158. Weissleder, R., A. S. Lee, B. A. Khaw, T. Shen, and T. J. Brady. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 182:381-385, 1992.
159. Weissleder, R., D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White, P. Jacobs, and J. Lewis. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am. J. Roentgenol. 152:167-173, 1989.
160. Weissleder, R., D. D. Stark, E. J. Rummeny, C. C. Compton, and J. T. Ferrucci. Splenic lymphoma: Ferrite-enhanced MR imaging in rats. Radiology 166:423-430, 1988.
161. 2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bioapplications. J. Mater. Chem. 14:2781-2786, 2004.
162. Zhang, R., M. L. Brennan, X. Fu, R. J. Aviles, G. L. Pearce, M. S. Penn, E. J. Topol, D. L. Sprecher, and S. L. Hazen. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286:2136-2142, 2001.
163. Zhao, M., D. A. Beauregard, L. Loizou, B. Davletov, and K. M. Brindle. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 7:1241-1244, 2001.
164. Zhao, M., L. Josephson, Y. Tang, and R. Weissleder. Magnetic sensors for protease assays. Angew Chem. Int. Ed. Engl. 42:1375-1378, 2003.
165. Zimmer, C., R. Weissleder, K. Poss, A. Bogdanova, S. C. Wright Jr., and W. S. Enochs. MR imaging of phagocytosis in experimental gliomas. Radiology 197:533-538, 1995.